Utility of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes - 04/11/16
Résumé |
A consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology held in February 2016 advocated expanding the use of continuous glucose monitoring (CGM) in the management of diabetes. Based on the data described in this paper, CGM use is shown to improve glucose control and reduce hypoglycemic events, and therefore has the potential to reduce the risk of acute and chronic complications of diabetes. Likely, all of the above would not only improve the quality of life and life expectancy of people with diabetes, but would also have a positive impact on health-related cost.
Le texte complet de cet article est disponible en PDF.Keywords : Technology, Type 1 diabetes mellitus, Type 2 diabetes mellitus, Continuous glucose monitoring
Plan
The authors have nothing to disclose. |
Vol 45 - N° 4
P. 895-904 - décembre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?